deucravacitinib,upadacitinib,baricitinib,tofacitinib
bms,eli lilly,abbvie,pfizer
['tofacitinib', ' psa', 'tofa', 'upadacitinib', 'baricitinib', 'deucra', 'axspa']
jak and tyk-2 inhibitors and indications in spa: tofacitinib pan jaki (as, psa) baricitinib jak1,2 upadacitinib jak1 (axspa, psa) deucravacitinib tyk2 (psa) carol langford, year in review #acr22 
MD PhD Consultant Rheumatologist &Physician,Assoc Medical Director,Digital Leader,NASS Trustee &Best Rheum Care,Visiting Fellow Henley Business School,ExecCoach